These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30596995)

  • 1. Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data.
    Zimmermann FM; Omerovic E; Fournier S; Kelbæk H; Johnson NP; Rothenbühler M; Xaplanteris P; Abdel-Wahab M; Barbato E; Høfsten DE; Tonino PAL; Boxma-de Klerk BM; Fearon WF; Køber L; Smits PC; De Bruyne B; Pijls NHJ; Jüni P; Engstrøm T
    Eur Heart J; 2019 Jan; 40(2):180-186. PubMed ID: 30596995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Improvement in Fractional Flow Reserve With Outcomes, Including Symptomatic Relief, After Percutaneous Coronary Intervention.
    Fournier S; Ciccarelli G; Toth GG; Milkas A; Xaplanteris P; Tonino PAL; Fearon WF; Pijls NHJ; Barbato E; De Bruyne B
    JAMA Cardiol; 2019 Apr; 4(4):370-374. PubMed ID: 30840026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study.
    Pijls NH; Fearon WF; Tonino PA; Siebert U; Ikeno F; Bornschein B; van't Veer M; Klauss V; Manoharan G; Engstrøm T; Oldroyd KG; Ver Lee PN; MacCarthy PA; De Bruyne B;
    J Am Coll Cardiol; 2010 Jul; 56(3):177-84. PubMed ID: 20537493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial.
    Lee JM; Kim HK; Park KH; Choo EH; Kim CJ; Lee SH; Kim MC; Hong YJ; Ahn SG; Doh JH; Lee SY; Park SD; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Koo BK; Lee BK; Yun KH; Hong D; Joh HS; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Hahn JY;
    Eur Heart J; 2023 Feb; 44(6):473-484. PubMed ID: 36540034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial.
    Zimmermann FM; Ding VY; Pijls NHJ; Piroth Z; van Straten AHM; Szekely L; Davidavicius G; Kalinauskas G; Mansour S; Kharbanda R; Östlund-Papadogeorgos N; Aminian A; Oldroyd KG; Al-Attar N; Jagic N; Dambrink JE; Kala P; Angeras O; MacCarthy P; Wendler O; Casselman F; Witt N; Mavromatis K; Miner SES; Sarma J; Engstrøm T; Christiansen EH; Tonino PAL; Reardon MJ; Otsuki H; Kobayashi Y; Hlatky MA; Mahaffey KW; Desai M; Woo YJ; Yeung AC; De Bruyne B; Fearon WF;
    Circulation; 2023 Sep; 148(12):950-958. PubMed ID: 37602376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease.
    Zimmermann FM; De Bruyne B; Pijls NH; Desai M; Oldroyd KG; Park SJ; Reardon MJ; Wendler O; Woo J; Yeung AC; Fearon WF
    Am Heart J; 2015 Oct; 170(4):619-626.e2. PubMed ID: 26386784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of fractional flow reserve guided complete revascularization versus infarct related artery only revascularization in patients with ST-elevation myocardial infarction and multivessel coronary artery disease.
    Neupane S; Singh H; Edla S; Altujjar M; Yamsaki H; Lalonde T; Rosman HS; Eggebrecht H; Mehta RH
    Coron Artery Dis; 2019 Sep; 30(6):393-397. PubMed ID: 31094897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary Artery Bypass Grafting or Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Diabetic Patients With Multivessel Disease.
    Di Gioia G; Soto Flores N; Franco D; Colaiori I; Sonck J; Gigante C; Kodeboina M; Bartunek J; Vanderheyden M; Van Praet F; Casselman F; Degriek I; Stockman B; Barbato E; Collet C; De Bruyne B
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009157. PubMed ID: 33040579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Fractional Flow Reserve-Guided Treatment for Acute Myocardial Infarction and Multivessel Disease: A Prespecified Analysis of the FRAME-AMI Randomized Clinical Trial.
    Hong D; Lee SH; Lee J; Lee H; Shin D; Kim HK; Park KH; Choo EH; Kim CJ; Kim MC; Hong YJ; Jeong MH; Ahn SG; Doh JH; Lee SY; Don Park S; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Guallar E; Cho J; Hahn JY; Kang D; Lee JM;
    JAMA Netw Open; 2024 Jan; 7(1):e2352427. PubMed ID: 38270954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the adverse clinical outcomes associated with fraction flow reserve-guided versus angiography-guided percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Bundhun PK; Yanamala CM; Huang F
    BMC Cardiovasc Disord; 2016 Dec; 16(1):249. PubMed ID: 27912739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial.
    Denormandie P; Simon T; Cayla G; Steg PG; Montalescot G; Durand-Zaleski I; le Bras A; le Breton H; Valy Y; Schiele F; Cuisset T; Vanzetto G; Levesque S; Goube P; Nallet O; Angoulvant D; Roubille F; Charles Nelson A; Chatellier G; Danchin N; Puymirat E
    Circ Cardiovasc Interv; 2021 Nov; 14(11):e011314. PubMed ID: 34420366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractional flow reserve-guided complete revascularization versus culprit-only revascularization in acute ST-segment elevation myocardial infarction and multi-vessel disease patients: a meta-analysis and systematic review.
    Wang LJ; Han S; Zhang XH; Jin YZ
    BMC Cardiovasc Disord; 2019 Mar; 19(1):49. PubMed ID: 30823897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiographic Severity of the Nonculprit Lesion and the Efficacy of Fractional Flow Reserve-Guided Complete Revascularization in Patients With AMI: FRAME-AMI Substudy.
    Seung J; Choo EH; Kim CJ; Kim HK; Park KH; Lee SH; Kim MC; Hong YJ; Ahn SG; Doh JH; Lee SY; Park SD; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Koo BK; Lee BK; Yun KH; Hong D; Joh HS; Choi KH; Park TK; Lee JM; Yang JH; Song YB; Choi SH; Gwon HC; Hahn JY;
    Circ Cardiovasc Interv; 2024 Jan; 17(1):e013611. PubMed ID: 37929584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine Fractional Flow Reserve Measurement After Percutaneous Coronary Intervention.
    van Bommel RJ; Masdjedi K; Diletti R; Lemmert ME; van Zandvoort L; Wilschut J; Zijlstra F; de Jaegere P; Daemen J; van Mieghem NM
    Circ Cardiovasc Interv; 2019 May; 12(5):e007428. PubMed ID: 31018666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
    Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
    JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary revascularization in patients with small-vessel disease.
    Puymirat E; Peace A; Mangiacapra F; Conte M; Ntarladimas Y; Bartunek J; Vanderheyden M; Wijns W; De Bruyne B; Barbato E
    Circ Cardiovasc Interv; 2012 Feb; 5(1):62-8. PubMed ID: 22319067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve.
    Xaplanteris P; Fournier S; Pijls NHJ; Fearon WF; Barbato E; Tonino PAL; Engstrøm T; Kääb S; Dambrink JH; Rioufol G; Toth GG; Piroth Z; Witt N; Fröbert O; Kala P; Linke A; Jagic N; Mates M; Mavromatis K; Samady H; Irimpen A; Oldroyd K; Campo G; Rothenbühler M; Jüni P; De Bruyne B;
    N Engl J Med; 2018 Jul; 379(3):250-259. PubMed ID: 29785878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial.
    van Nunen LX; Zimmermann FM; Tonino PA; Barbato E; Baumbach A; Engstrøm T; Klauss V; MacCarthy PA; Manoharan G; Oldroyd KG; Ver Lee PN; Van't Veer M; Fearon WF; De Bruyne B; Pijls NH;
    Lancet; 2015 Nov; 386(10006):1853-60. PubMed ID: 26333474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
    Engstrøm T; Kelbæk H; Helqvist S; Høfsten DE; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L;
    Lancet; 2015 Aug; 386(9994):665-71. PubMed ID: 26347918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.